<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04573075</url>
  </required_header>
  <id_info>
    <org_study_id>GI_observational_01_20</org_study_id>
    <nct_id>NCT04573075</nct_id>
  </id_info>
  <brief_title>Ghost Ileostomy (GI) Versus Loop Ileostomy (LI) After Colorectal Resections</brief_title>
  <acronym>GI_versus_LI</acronym>
  <official_title>Is a Ghost Ileostomy a Safe Alternative to a Protective Loop Ileostomy for Patients After Colorectal Resections ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Evangelisches Klinikum Köln Weyertal gGmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Evangelisches Klinikum Köln Weyertal gGmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Ghost Ileostomy (GI) as an alternative to a diverting protective Loop Ileostomy (LI) after&#xD;
      colorectal resection is offered the patients at risk preoperatively. A GI is only applied in&#xD;
      cases, who would receive a LI otherwise.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A protective loop ileostomy (LI) is applied to protect a critical anastomosis after left&#xD;
      sided colorectal resections. It is routinely indicated after low anterior rectal resection&#xD;
      because this location carries a high risk for anastomotic insufficiency due to poor blood&#xD;
      supply and tension of the bowel itself. A LI is also used to protect a primary anastomosis&#xD;
      after other colorectal resections, if the surgeon in charge deems it necessary. However, the&#xD;
      LI does not reduce the rate of insufficiencies (between 8-18%), but decreases the rate and&#xD;
      severity of the associated complications and its mortality.&#xD;
&#xD;
      Furthermore, the LI is associated with complications of its own. Stoma malfunction due to&#xD;
      torsion may cause a bowel obstruction, local complications may lead to an abscess or wound&#xD;
      dehiscence, and in the long term follow-up surgical interventions due to hernias at the stoma&#xD;
      site or adhesions with a consecutive ileus may become necessary.&#xD;
&#xD;
      Additionally, many patients are traumatized by the thought of a stoma. Thus, the routine&#xD;
      application of a LI is currently critically discussed and its need re-evaluated.&#xD;
&#xD;
      A Ghost ileostomy (GI) is an alternative. Instead of a real diverting stoma the suitable&#xD;
      small bowel loop is marked with a silicon strap, which is externalized through the abdominal&#xD;
      wall and fixed with sutures. No real stoma outlet needs to be formed. In case of an&#xD;
      anastomotic leakage (AL) the GI is easily converted to a LI by extracting the marked bowel&#xD;
      loop through the abdominal wall. Besides increasing patients' comfort, ileostomy-related&#xD;
      morbidity, hospital re-admissions for the closure of the ileostomy, and health care expenses&#xD;
      related to the stoma supply and complications can be avoided.&#xD;
&#xD;
      In a recent systematic review of the existing literature Baloyiannis et al. identified 11&#xD;
      studies with altogether 554 patients. They found a total complication rate of 13.9%, with&#xD;
      2,1% GI-specific adverse events. Although it is a safe and comfortable option for low- and&#xD;
      medium-risk patients it is still not established routinely.&#xD;
&#xD;
      Aim of the study:&#xD;
&#xD;
      The study wants to examen whether the routine use of a GI after colorectal resection with&#xD;
      primary anastomosis can reduce the number of LI needed. This should avoid the stoma&#xD;
      associated complications and the re-hospitalization for the stoma closure. A further endpoint&#xD;
      is the routine use of GI as an alternative has to ensure patients safety. No further risk&#xD;
      should result from this new intervention.&#xD;
&#xD;
      Study design:&#xD;
&#xD;
      Prospective clinical observational study&#xD;
&#xD;
      Method:&#xD;
&#xD;
      All patients after a colorectal resection with a primary anastomosis are offered the option&#xD;
      of a GI as an alternative to a LI preoperatively. They have to consent in a stoma, if the&#xD;
      surgeon in charge deems this necessary during the procedure. Written informed consent is&#xD;
      obtained prior to surgery. At the end of the colorectal resection the surgeon in charge&#xD;
      decided whether to shape a GI, a LI or no outlet. General criteria for a stoma are a redo&#xD;
      anastomosis, an ultralow rectal resection, peritonitis at the site of the anastomosis, or an&#xD;
      extended endometriosis resection in the pelvis. In case of emergency surgery a Hartman&#xD;
      procedure may become necessary due to the critical condition of the patient. A GI is only&#xD;
      applied in cases, who would have received a LI otherwise.&#xD;
&#xD;
      Technically, a silicon loop (Roeser Loops super maxi, Ref No 10.11522; Roeser Medical GmbH,&#xD;
      Bochum, Germany; conformity european (CE) 0481) marks a suitable terminal ileum loop and is&#xD;
      externalized through the 5 m trocar site regularly placed in the right upper quadrant of the&#xD;
      abdomen or a similar mini-incision in cases of open surgery. The loop is fixed with two&#xD;
      penetrating, non-absorbable sutures and closed with a wound dressing.&#xD;
&#xD;
      Postoperatively patients are observed on the intensive care unit (ICU) for 12-48 hours.&#xD;
      Further action - ultrasound, CT scan, and/or colonoscopy - is taken in cases of fever,&#xD;
      laboratory signs of inflammation (leucocyte count &gt;15x1000ul, procalcitonin &gt;1 ng/ml, or&#xD;
      C-reactive protein more than three times the initial value). Pelvic fluid collection, bowel&#xD;
      malfunction, or signs of anastomotic leakage will lead to a re-operation converting the GI to&#xD;
      a LI and an abdominal lavage with drainage, if necessary. In all other cases of GI the&#xD;
      silicon strap will be removed after the initiation of bowel function.&#xD;
&#xD;
      All patients included will be asked about their well being and medical treatments related to&#xD;
      their colorectal resection after their dismission in a follow-up phone call 6 months after&#xD;
      surgery. The study ends with this last survey.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 31, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Ghost ileostomy (short: ghost stoma) as an alternative to protective loop ileostomy or no outlet after colorectal resection</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of protective loop ileostomies avoided by the ghost stoma</measure>
    <time_frame>through study completion, an average of one year</time_frame>
    <description>The number of ghost ileostomies that did not need to be transformed to a loop ileostomy is counted.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity and Mortality after ghost ileostomy compared to the other groups</measure>
    <time_frame>through study completion, an average of one year</time_frame>
    <description>Surgical outcome measured concerning the postoperative morbidity and mortality according to the Clavien Dindo classification (CDC). CDC distinguishes: no complication = 0; mild complication without further intervention needed = 1; mild complication with medication like antibiotics needed=2; complication with further intervention needed =3a, complication with further intervention under general anesthesia needed =3b; septic complication =4; death =5.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>health care expenses</measure>
    <time_frame>through study completion, an average of one year</time_frame>
    <description>the amount of health care expenses spared by applying a ghost stoma compared to the general costs of a stoma closure, if applicable; results are expressed in €s per case</description>
  </other_outcome>
  <other_outcome>
    <measure>participants' satisfaction with the experimental intervention</measure>
    <time_frame>through study completion, an average of one year</time_frame>
    <description>measurement of participants satisfaction on a scale between 1 (not satisfied at all) to 4 (very satisfied)</description>
  </other_outcome>
  <other_outcome>
    <measure>operating time needed in cases of a ghost ileostomy</measure>
    <time_frame>through study completion, an average of one year</time_frame>
    <description>operating time in minutes of the group with a GI compared to the group with an LI and the group with no outlet</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Colorectal Surgery</condition>
  <arm_group>
    <arm_group_label>no outlet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>no outlet is used after colorectal resection and forming of a primary anastomosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>loop ileostomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>loop ileostomy is applied after colorectal resection and forming of a primary anastomosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ghost ileostomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ghost ileostomy or ghost stoma (synonyms) is performed after colorectal resection and forming of a primary anastomosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ghost ileostomy</intervention_name>
    <description>a loop of the small bowel is marked with a silicone strap and externalized through the abdominal wall to avoid a loop ileostomy</description>
    <arm_group_label>ghost ileostomy</arm_group_label>
    <other_name>Ghost stoma</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>loop ileostomy</intervention_name>
    <description>a protective loop ileostomy is applied after after colorectal resection and forming of a primary anastomosis</description>
    <arm_group_label>loop ileostomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>no outlet</intervention_name>
    <description>no further intervention is used after colorectal resection and forming of a primary anastomosis</description>
    <arm_group_label>no outlet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>participants eligibility is based in self-representation of gender identity</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia L Rudroff, PhD MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>EVK Koeln</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claudia L Rudroff, PhD MD</last_name>
    <phone>-49-221-479</phone>
    <phone_ext>32524</phone_ext>
    <email>claudia.rudroff@evk-koeln.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Evangelisches Klinikum Koeln Weyertal</name>
      <address>
        <city>Cologne</city>
        <state>Northrhine Westphalia</state>
        <zip>50931</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia L Rudroff, PhD MD</last_name>
      <phone>+49-221-479</phone>
      <phone_ext>32524</phone_ext>
      <email>claudia.rudroff@evk-koeln.de</email>
    </contact>
    <contact_backup>
      <last_name>Christoph Ulrici</last_name>
      <phone>+49-221-479</phone>
      <phone_ext>32311</phone_ext>
      <email>Christoph.ulrici@evk-koeln.de</email>
    </contact_backup>
    <investigator>
      <last_name>Alberto Vega Hernandez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Costanza Chiapponi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>https://www.awmf.org/leitlinien/detail/ll/021-007OL.html</url>
    <description>Standard operating procedure on the treatment of colorectal cancer in Germany</description>
  </link>
  <reference>
    <citation>Hüser N, Michalski CW, Erkan M, Schuster T, Rosenberg R, Kleeff J, Friess H. Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann Surg. 2008 Jul;248(1):52-60. doi: 10.1097/SLA.0b013e318176bf65. Review.</citation>
    <PMID>18580207</PMID>
  </reference>
  <reference>
    <citation>McDermott FD, Heeney A, Kelly ME, Steele RJ, Carlson GL, Winter DC. Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks. Br J Surg. 2015 Apr;102(5):462-79. doi: 10.1002/bjs.9697. Epub 2015 Feb 19. Review.</citation>
    <PMID>25703524</PMID>
  </reference>
  <reference>
    <citation>Ihnát P, Guňková P, Peteja M, Vávra P, Pelikán A, Zonča P. Diverting ileostomy in laparoscopic rectal cancer surgery: high price of protection. Surg Endosc. 2016 Nov;30(11):4809-4816. Epub 2016 Feb 22.</citation>
    <PMID>26902615</PMID>
  </reference>
  <reference>
    <citation>Sacchi M, Legge PD, Picozzi P, Papa F, Giovanni CL, Greco L. Virtual ileostomy following TME and primary sphincter-saving reconstruction for rectal cancer. Hepatogastroenterology. 2007 Sep;54(78):1676-8.</citation>
    <PMID>18019692</PMID>
  </reference>
  <reference>
    <citation>Baloyiannis I, Perivoliotis K, Diamantis A, Tzovaras G. Virtual ileostomy in elective colorectal surgery: a systematic review of the literature. Tech Coloproctol. 2020 Jan;24(1):23-31. doi: 10.1007/s10151-019-02127-2. Epub 2019 Dec 9.</citation>
    <PMID>31820192</PMID>
  </reference>
  <reference>
    <citation>Mari FS, Di Cesare T, Novi L, Gasparrini M, Berardi G, Laracca GG, Liverani A, Brescia A. Does ghost ileostomy have a role in the laparoscopic rectal surgery era? A randomized controlled trial. Surg Endosc. 2015 Sep;29(9):2590-7. doi: 10.1007/s00464-014-3974-z. Epub 2014 Dec 5.</citation>
    <PMID>25475516</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 12, 2020</study_first_submitted>
  <study_first_submitted_qc>September 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2020</study_first_posted>
  <last_update_submitted>September 27, 2020</last_update_submitted>
  <last_update_submitted_qc>September 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Evangelisches Klinikum Köln Weyertal gGmbH</investigator_affiliation>
    <investigator_full_name>Claudia Rudroff</investigator_full_name>
    <investigator_title>Head of the Department for Visceral Surgery and Surgery of the lower Gastrointestinal Tract</investigator_title>
  </responsible_party>
  <keyword>ghost ileostomy</keyword>
  <keyword>loop ileostomy</keyword>
  <keyword>colorectal resection</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

